[1]栾梦迪,吴立荣.院内发生的心肌梗死研究现况[J].心血管病学进展,2020,(10):1061.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.015]
　LUAN Mengdi,WU Lirong.Research Status of AMI occurring in Hospitalized Patients[J].Advances in Cardiovascular Diseases,2020,(10):1061.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.015]
点击复制

院内发生的心肌梗死研究现况()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年10期
页码:
1061
栏目:
综述
出版日期:
2020-10-25

文章信息/Info

Title:
Research Status of AMI occurring in Hospitalized Patients
作者:
栾梦迪; 吴立荣
(贵州医科大学附属医院心血管内科贵阳 贵州 550004)
Author(s):
LUAN Mengdi;  WU Lirong
(Department of Cardiology,The Affiliated Hospital of Guizhou Medical University,Guiyang 550004，Guizhou,China)
关键词:
院内急心肌梗死; 临床特点; 诊断; 治疗
Keywords:
In-hospital myocardial infarction; Clinical Characteristics; Diagnosis; Treatment
DOI:
10.16806/j.cnki.issn.1004-3934.2020.10.015
摘要:
急性心肌梗死是临床中常见的危重症，其发病率一直居高不下。但因为其他原因就诊，在住院期间发生心肌梗死的患者是一个被忽视却又十分重要的群体。院内发生的急性心肌梗死在临床特征、诊断、治疗以及预后等方面均与院外发生的急性心肌梗死不同，近年来受到越来越多的重视。现就院内发生的急性心肌梗死的相关研究及进展进行综述。
Abstract:
Acute myocardial infarction is a common critical illness in clinic,and its incidence is high.However,patients with myocardial infarction during hospitalization is a neglected but important group.In-hospital-onset acute myocardial infarction is different from out-patient-onset acute myocardial infarction in clinical characteristics,diagnosis,treatment,and prognosis.In-hospital-onset myocardial infarction has received more and more attention in recent years.The related research and progress of acute myocardial infarction in-hospital are now reviewed.

参考文献/References:

[1].,Townsend N,Scarborough P,et al. Cardiovascular disease in Europe 2014:epidemiological update[J]. Eur Heart J,2014,35(42):2950-2959.
[2].Benjamin EJ,Virani SS,Callaway CW,et al. Heart disease and stroke statistics-2018 update:a report from the American Heart Association[J]. Circulation,2018,137(12):e67-e492.
[3].中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 非ST段抬急冠状动脉综合征诊断和治疗指南(2016)[J]. 中华心血管病杂志,2017,45(5):359-376.
[4].,高润霖,刘力生.《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3):209-220.
[5].Yeh RW,Sidney S,Chandra M,et al. Population trends in the incidence and outcomes of acute myocardial infarction[J]. N Engl J Med,2010,362(23):2155-2165.
[6].急ST段抬心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783.
[7].中国医师协会急诊医师分会,国家卫健委能力建设继续教育中心急诊学专家委员会,中国医疗保健国际交流促进会急诊急救分会. 急综合征急诊快速诊治指南(2019)[J]. 中华急诊医学杂志,2019,28(4):421-428.,Bertel O,Urban P,et al. Inpatient versus outpatient onsets of acute myocardial infarction[J]. Eur J Intern Med,2015,26(6):414-419.
[8].Zahn R,Schiele R,Seidl K,et al. Acute myocardial infarction occurring in versus out of the hospital:patient characteristics and clinical outcom.Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group[J]. J Am Coll Cardiol,2000,35(7):1820-1826.
[9].Richmond T,Holoshitz N,Haryani A,et al. Adverse outcomes in hospitalized patients who develop ST-elevation myocardial infarction[J]. Crit Pathw Cardiol,2014,13(2):62-65.
[10].Zmyslinski RW,Lackland DT,Keil JE,et al. Increased fatality and difficult diagnosis of in-hospital acute myocardial infarction:comparison to lower mortality and more easily recognized pre-hospital infarction[J]. Am Heart J,1981,101(5):586-592.
[11].Kaul P,Federspiel JJ,Dai X,et al. Association of inpatient vs outpatient onset of ST-elevation myocardial infarction with treatment and clinical outcomes[J]. JAMA,2014,312(19):1999-2007.
[12].Borrayo-Sánchez G,Rosas-Peralta M,Ramírez-Arias E,et al. STEMI and NSTEMI:real-world study in Mexico (RENASCA)[J]. Arch Med Res,2018,49(8):609-619.
[13].Maynard C,Lowy E,Rumsfeld J,et al. The prevalence and outcomes of in-hospital acute myocardial infarction in the Department of Veterans Affairs Health System[J]. Arch Intern Med,2006,166(13):1410-1416.
[14].Dai X,Bumgarner J,Spangler A,et al. Acute ST-elevation myocardial infarction in patients hospitalized for noncardiac conditions[J]. J Am Heart Assoc,2013,2(2):e000004.
[15].Jaski BE,Grigoriadis CE,Dai X,et al. Factors associated with ineligibility for PCI differ between inpatient and outpatient ST-elevation myocardial infarction[J]. J Interv Cardiol,2016,29(4):363-369.
[16].Garberich RF,Traverse JH,Claussen MT,et al. ST-elevation myocardial infarction diagnosed after hospital admission[J]. Circulation,2014,129(11):1225-1232.
[17].Tahir K,Pauley E,Dai X,et al. Mechanisms of ST elevation myocardial infarction in patients hospitalized for noncardiac conditions[J]. Am J Cardiol,2019,123(9):1393-1398.
[18].Levine GN,Dai X,Henry TD,et al. In-hospital ST-segment elevation myocardial infarction:improving diagnosis,triage,and treatment[J]. JAMA Cardiol,2018,3(6):527-531.
[19].Busk M,Maeng M,Rasmussen K,et al.The Danish multicentre randomized study of fibrinolytic therapy vs.primary angioplasty in acute myocardial infarction (the DANAMI-2 trial):outcome after 3 years follow-up[J]. Eur Heart J,2008,29(10):1259-1266.
[20].Widimsky P,Bilkova D,Penicka M,et al. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention.Five years’ follow-up of the PRAGUE-2 Trial[J]. Eur Heart J,2007,28(6):679-684.
[21].Thune JJ,Hoefsten DE,Lindholm MG,et al. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty[J]. Circulation,2005,112(13):2017-2021.
[22].Danchin N,Popovic B,Puymirat E,et al. Five-year outcomes following timely primary percutaneous intervention,late primary percutaneous intervention,or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction:the FAST-MI programme[J]. Eur Heart J,2020,41(7):858-866.
[23].Brodie BR,Gersh BJ,Stuckey T,et al. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials[J]. J Am Coll Cardiol,2010,56(5):407-413.
[24].Dai X,Meredith D,Sawey E,et al. A quality improvement program for recognition and treatment of inpatient ST-segment elevation myocardial infarctions[J]. JAMA Cardiol,2016,1(9):1077-1079.

相似文献/References:

[1]王振伟 王涟 徐标.应激性心肌病患者临床特点及预后分析[J].心血管病学进展,2019,(5):831.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.041]
　WANG Zhenwei,WANG Lian,XU Biao.Clinical Features and Prognosis of Patients with Takotsubo Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(10):831.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.041]
[2]韦永诗 贾锋鹏.左回旋支急性完全闭塞的非ST段抬高型心肌梗死患者的临床及心电图特征综述[J].心血管病学进展,2020,(10):1057.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.014]
　WEI Yongshi,JIA Fengpeng.Clinical and Electrocardiogram Characteristics in Patients with NSTEMI Related to Acute Completely Occluded Left Circumflex Artery[J].Advances in Cardiovascular Diseases,2020,(10):1057.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.014]
[3]向军何玲李东林魏蜀亮彭泰峦彭慧.65岁以上急性主动脉壁内血肿患者临床特点及治疗[J].心血管病学进展,2021,(2):183.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.021]
[4]邓悦 周晓阳.免疫检查点抑制剂相关心脏毒性的临床特点及研究进展[J].心血管病学进展,2023,(10):905.[doi:10.16806/j.cnki.issn.1004-3934.2023.10.010]
　DENG YueZHOU Xiaoyang?/html>.Clinical Characteristics and Progress of?ardiac Toxicity Associated with Immune Checkpoint Inhibitors[J].Advances in Cardiovascular Diseases,2023,(10):905.[doi:10.16806/j.cnki.issn.1004-3934.2023.10.010]

更新日期/Last Update: 2020-12-21